Results 141 to 150 of about 374,365 (198)

Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. [PDF]

BMC Womens Health
Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C.   +4 more
europepmc   +1 more source

Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. [PDF]

PLoS One
Singata-Madliki M, Smit J, Beksinska M, Balakrishna Y, Avenant C, Beesham I, Seocharan I, Batting J, Hapgood JP, Hofmeyr GJ.   +9 more
europepmc   +1 more source

[Depot medroxyprogesterone acetate as contraceptive agent].

Revista colombiana de obstetricia y ginecologia, 1975
openaire   +1 more source

Long-term depot-medroxyprogesterone acetate and bone mineral density

Contraception, 1999
The association between long-term use of depot-medroxyprogesterone acetate (DMPA) and bone mineral density (BMD) has been controversial, as seen in three case-control studies in New Zealand, Thailand, and the United Kingdom. In the present case-controlled study of BMD, a group of 67 Chinese women who had used DMPA from 5-15 years was compared with 218 ...
Li, B, Tang, G, Yip, P, Fan, S, Tang, OS
openaire   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Safety of Depot Medroxyprogesterone Acetate

Lancet, The, 1991
MichèleG Bonhomme, D Malcolm Potts, JudithA Fortney, MelissaY Allen   +3 more
exaly   +2 more sources

Depot-medroxyprogesterone acetate: an update

Archives of Gynecology and Obstetrics, 2008
Depo-Provera is a contraceptive approved by the US Food and Drug Administration (FDA) since 1992 and used worldwide by more than 90 million women.Despite the fact that progestins are endogenous hormones that are secreted by the body, its excess might lead to detrimental health effects.
Sayed, Bakry, Zaher O, Merhi, Trudy J, Scalise, Mohamad S, Mahmoud, Ahmed, Fadiel, Frederick, Naftolin   +5 more
openaire   +2 more sources

Depot Medroxyprogesterone Acetate

2020
Depot medroxyprogesterone acetate (DMPA) is an injectable progestin-only contraceptive administered every 13 weeks. DMPA is an extremely effective contraceptive agent when used consistently. With typical use, approximately 6 out of 100 women will become pregnant in the first year of use, reflecting that some users do not return for repeat injections ...
Deanna C. McCullough, Kathryn M. Eraso, Andrew M. Kaunitz   +2 more
openaire   +1 more source

The Contraceptive Use of Depot Medroxyprogesterone Acetate

Clinical Obstetrics and Gynecology, 1995
Depot medroxyprogesterone acetate (DMPA) was the first popular long-acting progestogen-only contraceptive and is used by more than nine million women worldwide. It is one of the most convenient and effective yet readily reversible methods of contraception.
M, Hickey, I, Fraser
openaire   +2 more sources

Injectable Contraception with Depot Medroxyprogesterone Acetate

Drugs, 1993
Depot medroxyprogesterone acetate (DMPA) the only injectable contraception approved in the United States in 1992 is used by 8-9 million women in more than 90 countries. DMPA inhibits ovulation by the reduction of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) plasma levels.
Andrew M, Kaunitz, Allan, Rosenfield
openaire   +2 more sources